Menu
Back to Journals » Integrated Pharmacy Research and Practice » Volume 13 » default
ESCI
Impact Factor
Integrated Pharmacy Research and Practice
ISSN: 2230-5254
- View all (175)
- Volume 13, 2024 (4)
- Volume 12, 2023 (19)
- Volume 11, 2022 (20)
- Volume 10, 2021 (15)
- Volume 9, 2020 (24)
- Volume 8, 2019 (13)
- Volume 7, 2018 (14)
- Volume 6, 2017 (21)
- Volume 5, 2016 (11)
- Volume 4, 2015 (19)
- Volume 3, 2014 (9)
- Volume 2, 2013 (3)
- Volume 1, 2012 (3)
Archive: Volume 13, 2024
Original Research
Drug Use Evaluation of Tenofovir/Lamivudine/Dolutegravir (TLD) Fixed-Dose Combination for Initiation and Transition Among HIV-Infected Individuals Attending Lumame Primary Hospital, North West Ethiopia
Tegegne BA, Alehegn AA, Kassahun M
Integrated Pharmacy Research and Practice 2024, 13:31-42
Published Date: 18 April 2024
Original Research
Evaluation of Rational Medicines Use Based on World Health Organization Core Indicators: A Cross-Sectional Study in Five Health Districts in Mauritania
Ag Ahmed MA, Ravinetto R, Diop K, Trasancos Buitrago V, Dujardin C
Integrated Pharmacy Research and Practice 2024, 13:17-29
Published Date: 28 March 2024
Original Research
Biosimilars Would Reduce Health Care Costs But Are Yet Poorly Known – Patient Survey Study Among Biological Medicine Users
Pölkki M, Prami T
Integrated Pharmacy Research and Practice 2024, 13:9-16
Published Date: 3 February 2024
Original Research
Exploring Entrepreneurship in Pharmacy: Attitudes and Perceptions Among Saudi Pharmacists and Students
Alnuhait M, Alqurashi NF, Abdullatif GZ, Maash MS, Fagieha R, Alshareef H, Bahamdain FO, Alghamdi W, Alhifany AA
Integrated Pharmacy Research and Practice 2024, 13:1-8
Published Date: 18 January 2024